Destiny Pharma announces publication of XF-73 drug synergy data XF-73 shown to enhance the activity of two antibacterial drugs Findings may lead to improved treatments for lethal lung infections and infected diabetic foot ulcers caused by antimicrobial resistant bacteria Brighton, United Kingdom &nda...